A Study of IRESSA Treatment Beyond Progression in Addition to Chemotherapy Versus Chemotherapy Alone
Status:
Completed
Trial end date:
2019-11-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of gefitinib in patients who
have progressed on first line gefitinib, comparing continuing gefitinib in addition to
cisplatin plus pemetrexed combination chemotherapy versus cisplatin plus pemetrexed
combination chemotherapy alone.